DRUG · Mapped RxNorm record
Cisplatin
Normalized identity: cisplatinView linked drug · Find medicine records ·
Find other trials using this name
Clinical trial
Methoxyamine, Cisplatin, and Pemetrexed Disodium in Treating Patients With Advanced Solid Tumors or Mesothelioma That Cannot Be Removed by Surgery or Mesothelioma That Is Refractory to Pemetrexed Disodium and Cisplatin or Carboplatin
NCT02535312
Drugs and interventions used in this trial
3 registeredThese interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.
DRUG · Unmapped registry intervention
Methoxyamine
Find medicine records ·
Find other trials using this name
DRUG · Mapped RxNorm record
Pemetrexed Disodium
Normalized identity: pemetrexed disodiumView linked drug · Find medicine records ·
Find other trials using this name
No matching interventions in this trial.
Study at a glance
Registry-backedMethoxyamine, Cisplatin, and Pemetrexed Disodium in Treating Patients With Advanced Solid Tumors or Mesothelioma That Cannot Be Removed by Surgery or Mesothelioma That Is Refractory to Pemetrexed Disodium and Cisplatin or Carboplatin
Design: INTERVENTIONAL · Status: ACTIVE NOT RECRUITING · Phase: PHASE1, PHASE2
Read study objectives, eligibility and outcome measures at ClinicalTrials.govAdvertisement
Conditions
Advanced Malignant Solid Neoplasmunresolved
Advanced Pleural Malignant Mesotheliomaunresolved
Recurrent Pleural Malignant Mesotheliomaunresolved
Refractory Malignant Solid Neoplasmunresolved
Unresectable Solid Neoplasmunresolved
Interventions
CisplatinDRUG · verified · RxNorm: cisplatin
MethoxyamineDRUG
Pemetrexed DisodiumDRUG · verified · RxNorm: pemetrexed disodium
Sponsors & collaborators
National Cancer Institute (NCI)lead sponsor
Mapped research locations
Los AngelesCalifornia, United States2NashvilleTennessee, United States2BaltimoreMaryland, United States1PittsburghPennsylvania, United States1ColumbusOhio, United States1AuroraColorado, United States1Ann ArborMichigan, United States1RochesterMinnesota, United States1SacramentoCalifornia, United States1MadisonWisconsin, United States1DuarteCalifornia, United States1PasadenaCalifornia, United States1
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT02535312 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.